Tekla Capital Management Upped Its Accelerate Diagnostics (AXDX) Holding; Shorts at Wmih (WMIH) Lowered By 2.92%

January 13, 2018 - By Louis Casey

Wmih Corporation (NASDAQ:WMIH) had a decrease of 2.92% in short interest. WMIH’s SI was 5.72M shares in January as released by FINRA. Its down 2.92% from 5.89M shares previously. With 810,800 avg volume, 7 days are for Wmih Corporation (NASDAQ:WMIH)’s short sellers to cover WMIH’s short positions. The SI to Wmih Corporation’s float is 3.19%. The stock decreased 5.06% or $0.0521 during the last trading session, reaching $0.9779. About 903,399 shares traded or 24.05% up from the average. WMIH Corp. (NASDAQ:WMIH) has declined 49.79% since January 13, 2017 and is downtrending. It has underperformed by 66.49% the S&P500.

Tekla Capital Management Llc increased Accelerate Diagnostics Inc. (AXDX) stake by 50% reported in 2017Q3 SEC filing. Tekla Capital Management Llc acquired 50,000 shares as Accelerate Diagnostics Inc. (AXDX)’s stock rose 20.30%. The Tekla Capital Management Llc holds 150,000 shares with $3.37M value, up from 100,000 last quarter. Accelerate Diagnostics Inc. now has $1.52B valuation. The stock decreased 1.26% or $0.35 during the last trading session, reaching $27.35. About 284,797 shares traded. Accelerate Diagnostics, Inc. (NASDAQ:AXDX) has risen 147.12% since January 13, 2017 and is uptrending. It has outperformed by 130.42% the S&P500.

WMIH Corp., through its subsidiary, WM Mortgage Reinsurance Company, Inc., engages in reinsurance business with respect to mortgage insurance in runoff mode. The company has market cap of $195.58 million. The firm was formerly known as WMI Holdings Corp. and changed its name to WMIH Corp. in May 2015. It has a 3.64 P/E ratio.

Among 4 analysts covering Accelerate Diagnostics (NASDAQ:AXDX), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Accelerate Diagnostics had 9 analyst reports since August 25, 2015 according to SRatingsIntel. William Blair initiated the shares of AXDX in report on Friday, January 8 with “Outperform” rating. The firm has “Overweight” rating given on Wednesday, December 16 by Piper Jaffray. The company was reinitiated on Wednesday, July 12 by BTIG Research. The firm has “Neutral” rating by BTIG Research given on Wednesday, December 13. Piper Jaffray maintained the shares of AXDX in report on Thursday, August 3 with “Buy” rating. JP Morgan initiated Accelerate Diagnostics, Inc. (NASDAQ:AXDX) rating on Thursday, March 24. JP Morgan has “Overweight” rating and $17 target. BTIG Research upgraded the shares of AXDX in report on Tuesday, August 25 to “Neutral” rating. The company was maintained on Sunday, September 17 by Piper Jaffray. JP Morgan maintained it with “Overweight” rating and $25 target in Tuesday, August 9 report.

Investors sentiment decreased to 1.63 in Q3 2017. Its down 1.37, from 3 in 2017Q2. It dived, as 15 investors sold AXDX shares while 20 reduced holdings. 19 funds opened positions while 38 raised stakes. 21.32 million shares or 11.33% more from 19.15 million shares in 2017Q2 were reported. 9,978 are held by Art Advisors Ltd Liability Com. Jane Street Grp Lc accumulated 91,446 shares. Verition Fund Management Limited Co has 0.02% invested in Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Fincl Bank Of Ny Mellon Corp accumulated 0% or 126,863 shares. Citadel Advisors Limited Liability Company reported 29,556 shares. Bokf Na holds 0.01% of its portfolio in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) for 11,384 shares. Morgan Stanley owns 136,118 shares. Pnc Fincl Gp holds 0% or 3,200 shares. Birchview Capital LP owns 2.18 million shares. 9,000 are held by Barbara Oil. Thompson Management accumulated 17,500 shares. Artemis Investment Mgmt Llp owns 0.05% invested in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) for 100,111 shares. Plante Moran Financial Advsrs Limited Liability Corp accumulated 4,000 shares or 0.05% of the stock. Parametric Portfolio Assoc Limited Liability owns 28,284 shares for 0% of their portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) stated it has 0% of its portfolio in Accelerate Diagnostics, Inc. (NASDAQ:AXDX).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>